At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic
In Brief
A Phase 4 clinical trial evaluating Sublingual Tablet for Spine Fusion and 2 related conditions. Completed, enrolled 199 participants across 1 site.
Detailed Summary
In this study the investigators plan to examine the perioperative use of sufentanil sublingual (SL) in the analgesic regimen for spine surgery, one of the most common surgeries performed in the US. Patients undergoing spinal fusion surgery often experience severe pain during the first three postoperative days. Currently, no data are available for this patient population which routinely experiences moderate to severe acute pain. The investigators will analyze whether sufentanil SL is associated with lower opioid consumption in the post anesthesia care unit and pain scores.
Study Details
Timeline
Interventions
sufentanil SL 30mcg administered sublingually to patients undergoing spine surgery before extubation and during recovery